Sec Form 4 Filing - Luzon Ronen @ My Size, Inc. - 2020-05-25

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Luzon Ronen 2. Issuer Name and Ticker or Trading Symbol My Size, Inc. [ MYSZ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) HAYARDEN 4 3. Date of Earliest Transaction (MM/DD/YY) 05/25/2020 (Street) AIRPORT CITY, L37010000 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Option to purchase Common Stock (right to buy) $ 18.15 05/25/2020 D 10,000 ( 1 ) 07/24/2022 Common Stock, $.001 par value per share 10,000 ( 2 ) 0 D Option to purchase Common Stock (right to buy) $ 1.04 05/25/2020 A 10,000 ( 1 ) 07/24/2023 Common Stock, $.001 par value per share 10,000 ( 2 ) 10,000 D Option to purchase Common Stock (right to buy) $ 11.4 05/25/2020 D 6,667 ( 1 ) 05/29/2024 Common Stock, $.001 par value per share 6,667 ( 3 ) 0 D Option to purchase Common Stock (right to buy) $ 1.04 05/25/2020 A 6,667 ( 1 ) 05/29/2025 Common Stock, $.001 par value per share 6,667 ( 3 ) 6,667 D Option to purchase Common Stock (right to buy) $ 11.4 05/25/2020 D 33,334 ( 4 ) 05/29/2024 Common Stock, $.001 par value per share 33,334 ( 3 ) 0 D Option to purchase Common Stock (right to buy) $ 1.04 05/25/2020 A 33,334 ( 4 ) 05/29/2025 Common Stock, $.001 par value per share 33,334 ( 3 ) 33,334 D Option to purchase Common Stock (right to buy) $ 18.15 05/25/2020 D 10,000 ( 1 ) 07/24/2022 Common Stock, $.001 par value per share 10,000 ( 2 ) 0 I See Footnote ( 5 ) Option to purchase Common Stock (right to buy) $ 1.04 05/25/2020 A 10,000 ( 1 ) 07/24/2023 Common Stock, $.001 par value per share 10,000 ( 2 ) 10,000 I See Footnote ( 5 ) Option to purchase Common Stock (right to buy) $ 11.4 05/25/2020 D 5,334 ( 1 ) 05/29/2024 Common Stock, $.001 par value per share 5,334 ( 3 ) 0 I See Footnote ( 5 ) Option to purchase Common Stock (right to buy) $ 1.04 05/25/2020 A 5,334 ( 1 ) 05/29/2025 Common Stock, $.001 par value per share 5,334 ( 3 ) 5,334 I See Footnote ( 5 ) Option to purchase Common Stock (right to buy) $ 11.4 05/25/2020 D 17,000 ( 4 ) 05/29/2024 Common Stock, $.001 par value per share 17,000 ( 3 ) 0 I See Footnote ( 5 ) Option to purchase Common Stock (right to buy) $ 1.04 05/25/2020 A 17,000 ( 4 ) 05/29/2025 Common Stock, $.001 par value per share 17,000 ( 3 ) 17,000 I See Footnote ( 5 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Luzon Ronen HAYARDEN 4 AIRPORT CITY, L37010000 X Chief Executive Officer Signatures /s/ Ronen Luzon 06/08/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. ( 2 )Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. ( 3 )Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. ( 4 )Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021. ( 5 )Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).

Remarks: On November 15, 2019, the Company implemented a 1-for-15 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.